Clinical Trials Browser

Active not recruiting × OTHER × ensartinib × Clear all

NCT04837716 2026-02-19

Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03420508 2026-02-05

Treating Patients With Melanoma and ALK Alterations With Ensartinib

Phase 2 Active not recruiting

Melanoma

NCT05491811 2024-09-19

EAGLE

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung